InvestorsHub Logo
Followers 787
Posts 38718
Boards Moderated 9
Alias Born 06/20/2009

Re: BigBadWolf post# 51929

Tuesday, 06/21/2022 9:55:22 AM

Tuesday, June 21, 2022 9:55:22 AM

Post# of 64317
JadiCell for COVID-19 (Phase III ongoing #19757)
JadiCell for COPD (IND #28508)
JadiCell for Chronic Traumatic Encephalopathy (IND #27377)
JadiCell for Idiopathic Pulmonary Fibrosis (Late Preclinical)
StemVacs Dendritic Cells for Breast Cancer (IND #28508)
StemVacs-V iPSC Derived Tumor Endothelial Targeting Vaccine (Late Preclinical)


Bio next week Post by TimGDixon » Fri Jun 10, 2022 6:18 pm

Most of you know next week BIO happens and Venvalo Group will be there to present the following opportunities on our behalf in One-on-One meetings for out-licensing and collaborative/partnerships. There will be no recordings as these are pre-arranged one on one meetings that are rapid so you can get maximum exposure. This is where pharma biopharma shops and something like 3,682 companies will be present.
JadiCell for COVID-19 (Phase III ongoing #19757)
JadiCell for COPD (IND #28508)
JadiCell for Chronic Traumatic Encephalopathy (IND #27377)
JadiCell for Idiopathic Pulmonary Fibrosis (Late Preclinical)
StemVacs Dendritic Cells for Breast Cancer (IND #28508)
StemVacs-V iPSC Derived Tumor Endothelial Targeting Vaccine (Late Preclinical)


https://forum.therapeuticsolutionsint.com/viewtopic.php?p=4624&hilit=Venvalo+Group#p4624


Alpha Male always Caribbean Wolf Pack Strong The Society of Slayers...

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TSOI News